Introduction
Cigarette smoking is an independent risk factor for that more smokers achieve TIMI grade 3 flow in the infarct-related vessel than do non-smokers.7,8,10-coronary atherosclerosis, acute myocardial infarction and sudden death,1,2 but paradoxically the 12 Smoking is associated with a hypercoagulable state, particularly higher fibrinogen, compared with short-term mortality of smokers admitted with acute myocardial infarction (AMI) is 30 to 50% that of non-smokers.14,15 This may predispose smokers to thrombotic vessel occlusion at an earlier stage of non-smokers. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] Smokers are younger than nonsmokers and have fewer risk factors at presentation, atheromatous disease than non-smokers, leading to coronary occlusions which are more susceptible but even after adjusting for these factors, smoking remains independently associated with lower morto thrombolysis. Alternatively, smokers may have a more complete fibrinolytic response to thromtality.7-11 The most important factor relating smoking to survival after thrombolysis for AMI appears to be bolysis, leading to improved vessel recanalization for the same degree of stenosis compared with nonthe Sysmex Model CA-1000 coagulation analyser. This was accurate for fibrinogen levels from 0.05 smokers.
The majority of data on the effect of smoking on to 50 g/l. prognosis following thrombolysis in AMI have come from thrombolytic or angiographic trials, which excluded many patients encountered in routine Electrocardiographic evidence of practice. [5] [6] [7] [8] [10] [11] [12] We chose to study unselected myocardial reperfusion consecutively admitted patients with AMI, to determine if lower mortality was found in smokers A 12-lead ECG was recorded immediately prior to treated in routine clinical practice, and to explore initiation of thrombolysis and at 60, 90 and 180 min further explanatory variables linked to their better thereafter. The ST segment was measured by calliper prognosis. We hypothesized that in addition to at 80 ms beyond the J point. The lead of maximum demographic differences and coronary factors ST elevation was determined from the baseline ECG, encouraging vessel recanalization, smokers might and used for subsequent measurements. ST segment also have a systemic fibrinolytic response to thromdeflection on serial 12-lead ECGs up to 180 min was bolysis which is more favourable than that of noncompared with the baseline ECG. A 50% fall in ST smokers.
segment elevation is a well-validated marker of coronary patency, while a failure to achieve a 25% fall in ST segment elevation is a good predictor of poor clinical outcome.18-22
Methods

Patients
Patients studied were a consecutive series with first
Cardiac mortality
myocardial infarction who received thrombolysis Patients were followed for 36 days. The cause of within 12 h of onset of chest pain. Criteria for any deaths within 36 days was sought from hospital thrombolytic administration were chest pain for records or the General Practitioner after hospital 30 min or greater, and ST elevation in two or more discharge. Cardiac deaths were identified, and leads on a standard 12-lead ECG (0.1 mV limb leads, patients were excluded if they suffered non-cardiac 0.2 mV chest leads). There was no age limit, and death (n=5) or the cause of death was unknown the conventional contra-indications to thrombolysis (n=1). Follow-up was complete. were observed.16 Streptokinase (1.5 MU intravenously over 60 min) was given unless the patient was hypotensive on presentation (systolic blood pressure <90 mmHg) or where streptokinase intolerance or history (6/37) and non-smokers 26.6% (17/64). Inclusion of non-cardiac deaths did not affect the statistically Table 1 summarizes patient baseline characteristics, ECG data and 60-min plasma fibrinogen level significant association between smoking and mortality. Mortality was lower in patients with plasma according to smoking history: 48% were current smokers, 19% previous smokers and 33% had never fibrinogen <0.5 g/l at 60 min following initiation of thrombolysis, at 4.5% (5/112), compared with 17.1% smoked. Current smokers were significantly younger than non-smokers (60.5 years vs. 67.0 years, (7/41) at 0.5 g/l or above ( p<0.05). Age and 25% ST fall by 180 min were the only factors associated p<0.001) and were less likely to have hypertension (15% vs. 33%, p<0.005). Pain-to-treatment time did with mortality to differ between groups defined by smoking history. not vary between groups defined by smoking history. Values are means±SD except where stated. *Current compared with previous or non-smoker. **Median (10-90th centile). ***Geometric mean (SD). gen at 60 min after thrombolysis between current ST change, plasma fibrinogen and cardiac smokers who achieved a 25% ST fall at 180 min mortality compared with smokers who did not achieve a 25% Table 3 summarizes the relationship between plasma fall in ST segments. However in non-smokers, persistfibrinogen at 60 min, 25% ST segment change by ent ST elevation was associated with higher fibrino-180 min and subsequent cardiac mortality for current gen. In the whole population, mean plasma smokers compared with non-smokers. In current and fibrinogen at 60 min was higher in patients who non-smokers, failure to achieve a 25% fall in ST subsequently did not achieve a 25% fall in ST segment elevation was associated with higher mortalelevation by 180 min than in those who did: 0.36 g/l ity, although this was considerably higher for non-(range 0.16-0.81) compared with 0.25 g/l (0.12-0.55) ( p<0.05). smokers. There was no difference in plasma fibrino- 
Multivariate analysis of cardiac mortality Discussion
All prognostic factors were entered into a multiple A strong relationship between cigarette smoking and logistic regression analysis with cardiac death as the mortality following thrombolysis for AMI has been dependent variable. This analysis was carried out on consistently found but the nature of this relationship patients with complete data available for all proremains unknown. This study is the first to investigate gnostic variables (n=121). The best model-fitting the effect of smoking on cardiac mortality in unselecwas achieved with age expressed as quintiles ted, consecutive patients all receiving thrombolysis ( p<0.05 for comparison of deviances of quintile by standard indications for first AMI. It is also the and linear models), while the other continuous first to investigate the systemic fibrinolytic response variables were expressed appropriately as linear to thrombolysis as a prognostic factor related to terms. Interactions between all the prognostic varibetter outcome in smokers. ables included in the model were tested. There was a significant interaction between post-thrombolysis Relationship between smoking and cardiac fibrinogen and smoking history in predicting cardiac mortality mortality. When all prognostic variables were entered into the statistical model, time to thrombolysis and Current smokers had significantly lower 36-day mortality than previous or non-smokers. This confirms the post-thrombolysis fibrinogen were independent prefindings of previous studies but extends the observadictors of cardiac mortality. Smoking history was not tion to routine clinical practice.3-13 Previous data have independently associated with cardiac mortality after mostly come from patients selected for studies adjustment for other prognostic factors. After fitting designed to evaluate thrombolytic agents or post-AMI the interaction between fibrinogen and smoking in angiography.5-8,10-12 Three previous trials involving the model, fibrinogen was not an independent preunselected patients included a mix of thrombolysed dictor of cardiac mortality. The overall goodness of and non-thrombolysed subjects,3,9,13 whereas our aim fit of the model was satisfactory (Homser-Lemeshow was specifically to investigate the interaction between test, p=0.9).
smoking and outcome after thrombolysis. Mortality in Figure 1 shows the odds ratios for cardiac mortalcurrent smokers (3.4%) was comparable to that in ity, comparing current with non-smokers after stepprevious studies, but mortality in non-smokers was wise adjustment for other relevant variables. The higher than reported for recent thrombolysis trials, at unadjusted odds ratio for cardiac mortality in current 24.2% compared with 9-12%.7,8,10 This is likely to smokers was 0.3 (95% CI 0.2-0.7) ( p<0.01).
be due to the exclusion of older, higher-risk, predomiCurrent smoking was independently associated with nantly non-smokers from thrombolytic trials. In this lower cardiac mortality after adjustment for age, study, an ex-smoker was defined as a subject who hypertension, diabetes mellitus, ECG evidence of had not smoked for at least one week prior to reperfusion and time to thrombolysis: odds ratio 0. 4 presentation. This cut-off was chosen as the acute (95%CI 0.3-0.9), ( p<0.05). After adjustment for effects of smoking on coagulation and endothelial post-thrombolysis fibrinogen, current smoking was function are likely to have diminished by this time; not associated with lower cardiac mortality at the however, the effects of smoking in promoting prema-5% confidence level: odds ratio 0.5 (95%CI 0.4-1.1) ture atherosclerosis would not change within a week. ( p=0.1).
These two mechanisms of smoking-related disease presumably lead to the intermediate mortality result in ex-smokers. However, there were insufficient numbers of ex-smoker deaths to allow meaningful statistical analysis of ex-smokers as a separate group in multivariate analysis.
Demographic factors
In this and previous studies, smokers had demographic characteristics at presentation, particularly lower age, which were associated with survival advantage compared with non-smokers.3-13 However in multivariate analysis, we and others found that for cardiac mortality after adjustment for demo-graphics was 0.4 (95% CI 0.3-0.9) for current gen and smoking history were both strongly associated with cardiac mortality. In multivariate analysis, compared with non-smokers.
there was a significant interaction between postthrombolysis plasma fibrinogen and smoking history
Pre-admission mortality in predicting cardiac mortality. In logistic regression Smoking is associated with an increased risk of sudden analysis comparing risk of cardiac mortality between death, and it has been suggested that better survival current smokers and non-smokers, current smoking in smokers following hospital admission could be was associated with survival independent of all explained by the pre-hospital death of high-risk prognostic variables except post-thrombolysis fibrinosmokers.23 This suggestion was based on the observagen. However, the last result should be cautiously tion that although hospital mortality was lower in interpreted because, although not significant at the smokers following AMI, total mortality (pre-and post-5% level, the odds ratio for current smokers mortality hospital admission) was not. However, pre-admission was only 0.5 compared with non-smokers after mortality in that study was unexpectedly high at adjustment for fibrinogen. Thus statistical insignific-34.0-38.4%, and did not differ significantly between ance may simply be a consequence of the relatively groups according to smoking history. In addition, postsmall number of end-points. The residual odds ratio admission mortality in current smokers was higher of 0.5 after adjustment for all available prognostic than in this and previous studies.3-13 It is unlikely that variables indicates that there are further important lower hospital mortality in smokers can be explained associations with mortality, for example coronary solely by higher pre-admission mortality.
anatomy, which were not in our model. The mechanism associating cigarette smoking,
Reperfusion in smokers
systemic fibrinolysis and cardiac mortality is likely to be via more effective post-thrombolysis vessel We chose to investigate myocardial reperfusion recanalisation. Among non-smokers there was a large because it strongly predicts short-term mortality and subgroup with suboptimal myocardial reperfusion by can be estimated non-invasively by ST segment ECG criteria and less complete systemic fibrinolysis measurement. Significantly more non-smokers failed who had 36-day mortality of 40%. A similar highto achieve a 25% fall in ST elevation by 180 min risk subgroup was not evident among smokers. This compared with current smokers. This level of persistis consistent with the hypothesis that current smokers ent ST elevation is associated with suboptimal infarctas a group are less likely than non-smokers to have related vessel recanalization, and high short-term a suboptimal fibrinolytic response to thrombolysis mortality.22,24 These ECG data are consistent with and therefore have overall better coronary recanalizaangiographic studies, where more non-smokers than tion and lower mortality. The potential mechanism smokers had suboptimal vessel recanalization (TIMI which relates enhanced post-thrombolytic systemic grades 0-2) after thrombolysis.7,8,10-12 Higher rates fibrinolysis in smokers is unknown, but could involve of suboptimal recanalization were associated with increased plasma fibrinolytic activity.26-29 higher mortality in non-smokers which, when entered It is important that this study is considered as into multivariate analysis, accounted for the statistical hypothesis-generating and not hypothesis-proving. In difference in mortality between smokers and nonmultivariate analyses of this size, non-significant smokers. 7, 8, [10] [11] [12] results are inconclusive, and very strong associations are necessary for a variable to be significant. This
Enhanced systemic fibrinolytic response to new hypothesis in the smokers' paradox should now thrombolysis in smokers?
be tested in a larger patient group. Better post-thrombolysis coronary artery recanalization has been attributed to relatively more thrombotic and Conclusions less atheromatous coronary occlusions in smokers compared with non-smokers.7,12 However, in all studCigarette smoking was associated with lower shortterm cardiac mortality in unselected patients receivies where it was measured, the severity of residual stenoses in infarct-related vessels after thrombolysis ing thrombolysis for first AMI. Current cigarette smoking was associated with lower mortality indedid not differ between smokers and non-smokers. 8, 10, 11 The occlusive thrombus in smokers may have a pendent of all prognostic variables except plasma fibrinogen at 60 min after initiation of thrombolysis. different composition to that in non-smokers making it more susceptible to thrombolysis, but we hypothesFewer smokers had ECG evidence of failed reperfusion than non-smokers. Non-smokers with ECG evidize that smokers may have enhanced intrinsic fibrinolysis resulting in improved vessel recanalization.
ence of failed reperfusion had 40% short-term mortality and had significantly higher plasma fibrinoData presented in this study provide some support for this hypothesis. Post-thrombolysis plasma fibrinogen than current smokers. These data suggest that of the infarct-related coronary artery after myocardial lower cardiac mortality in smokers relates to more 
